Smartleaf Asset Management
CLPT icon

Smartleaf Asset Management’s ClearPoint Neuro CLPT Stock Holding History

Smartleaf Asset Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-48
Closed -$933 – 3662
2026
Q2 		$933 Hold
48
– – ﹤0.01% 3105
2026
Q1 		$416 Hold
48
– – ﹤0.01% 3253
2025
Q4 		$651 Hold
48
– – ﹤0.01% 3228
2025
Q3 		$1.04K Buy
+48
New +$565 ﹤0.01% 2740
2025
Q2 		– Sell
-48
Closed -$574 – 2773
2025
Q1 		$574 Buy
+48
New +$746 ﹤0.01% 2681

Other funds holding CLPT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Lane Generational
Lane Generational Dover, Massachusetts $111M AUM 16.63% 1-Year Est. Return
Pekin Hardy Strauss
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 25.53% 1-Year Est. Return
Compass Financial Management
Compass Financial Management Tampa, Florida $926M AUM
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Parsons Capital Management
Parsons Capital Management Providence, Rhode Island $2.29B AUM 21.99% 1-Year Est. Return
Taylor Frigon Capital Management
Taylor Frigon Capital Management Scottsdale, Arizona $197M AUM 35.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Smartleaf Asset Management's CLPT Position: Q3 2026 in Review

Smartleaf Asset Management sold out of ClearPoint Neuro (CLPT) in Q3 2026, closing a stake of 48 shares — an estimated $933 sold.

Smartleaf Asset Management first reported a position in CLPT in Q1 2025 and held it in 5 quarters. The position peaked at $1.04K in Q3 2025. 55 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.

  • Smartleaf Asset Management reported no remaining ClearPoint Neuro position as of Q3 2026 after selling out during the quarter.
  • Smartleaf Asset Management sold 48 ClearPoint Neuro shares in Q3 2026, an estimated $933.
  • Smartleaf Asset Management first reported a position in ClearPoint Neuro in Q1 2025 and held it in 5 quarters.
  • Smartleaf Asset Management's ClearPoint Neuro position peaked at $1.04K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.